Analysis of Microbiota Variations in Industry Workers Working Different Shifts and Impact of a Nutritional Intervention
1 other identifier
interventional
18
1 country
1
Brief Summary
Shift workers are a growing population. It is well established that these workers face an increased risk of developing chronic diseases, but the underlying mechanisms remain debated. Various factors such as internal circadian desynchronization, unhealthy lifestyle behaviours, and lack of sleep interact in complex ways. Recently, it has been suggested that the gut microbiota (GM) may play an important role in this increased risk. The goal of this study is to describe the variations of the GM composition in shift workers across three different rotating weekly shifts (morning, afternoon, night) and to measure the impact of a 3- week walnuts supplementation intervention consisting in a controlled experimental study. Therefore, we propose a 6-weeks study including an observational and an experimental part. First, in the observational part, we will compare the gut microbiota of shift workers across three shifts (morning, afternoon and night). In the second part of the study, participants will add to their usual intakes a daily serving of nuts (30g). Again, we will compare the gut microbiota composition across the three types of shifts. During the study, participants will record their food intake, sleep and defecation time. We will also monitor their blood glucose levels continuously during the 4 first weeks of the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 12, 2021
CompletedFirst Submitted
Initial submission to the registry
June 2, 2021
CompletedFirst Posted
Study publicly available on registry
June 9, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2022
CompletedMay 16, 2022
May 1, 2022
12 months
June 2, 2021
May 12, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in gut microbiota composition between the first and last day of each type of shift (observation phase)
Change in relative abundance of bacteria phyla between the first and last day of each type of shift (AM, PM, N). Assessed by 16S rRNA sequencing approach.
3 weeks (6 measurements over time)
Change in gut microbiota composition between the first and last day of each type of shift (observation vs intervention)
Change in relative abundance of bacteria phyla between the first and last day of each type of shift (AM, PM, N). Assessed by 16S rRNA sequencing approach.
6 weeks (12 measurements over time)
Secondary Outcomes (2)
Area under the blood glucose curve between each type of shift
3 weeks
Area under the blood glucose curve in AM shift (observation vs intervention)
week 1 vs 4
Other Outcomes (1)
Mean weekly frequency of defecation between each type of shift
6 weeks
Study Arms (1)
Intervention walnuts
EXPERIMENTALDuring the 3 last weeks of the study, the participants will eat a 30g daily walnut serving
Interventions
30g of plain walnuts in addition to habitual food intakes
Eligibility Criteria
You may qualify if:
- Working 3x8 shifts (weekly rotations between AM, PM and N shifts) for at least 3 months prior to the study
- No anticipated changes in shift work planning
- No prebiotics or probiotics supplements.
You may not qualify if:
- Antibiotic and/or immunomodulator use in the last 3 months or during the study
- Change in medication during the last month or during study
- Inflammatory bowel disease or important gut surgery
- Nuts allergy
- Major digestive tract surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sophie Bucher Della Torrelead
- University Hospital, Genevacollaborator
Study Sites (1)
School of Health Sciences Geneva
Geneva, Carouge, 1227, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor Assistant
Study Record Dates
First Submitted
June 2, 2021
First Posted
June 9, 2021
Study Start
April 12, 2021
Primary Completion
March 31, 2022
Study Completion
September 30, 2022
Last Updated
May 16, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Data will be available within 12 months of study completion
- Access Criteria
- At the end of the project the data will be deposited in the Yareta repository developed by the University of Geneva OR in an institutional repository. This choice will ensure that data is archived and shared in accordance with FAIR principles.
De-identified individual participant data for all primary and secondary outcome measure will be made available.